Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73

被引:58
作者
Gaiddon, C [1 ]
Lokshin, M
Gross, I
Levasseur, D
Taya, Y
Loeffler, JP
Prives, C
机构
[1] Univ Strasbourg 1, Equipe Accecil Signalisat Mol & Neurodegenetescen, F-67000 Strasbourg, France
[2] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[3] INSERM, U381, F-67000 Strasbourg, France
[4] Natl Canc Ctr, Tokyo 10040045, Japan
关键词
D O I
10.1074/jbc.M300251200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p73 transcription factors are members of the p53 family and participate in developmental processes and DNA damage response. p73 expression was shown to be regulated during the cell cycle, suggesting that p73 might play a role in cell growth and might be a target for cyclin-dependent kinases. Consistent with this hypothesis, we discovered that p73 interacts physically with various cyclins (A, B, D, and E). Furthermore, cyclin A/CDK1/2, cyclin B/CDK1/2, and cyclin E/CDK2 complexes can phosphorylate multiple p73 isoforms in vitro at threonine 86. A specific antibody directed against phosphorylated Thr(86) showed that this site is phosphorylated in vivo and that such phosphorylation is regulated in a cell cycle-dependent manner. Thr(86) phosphorylation is induced during S phase and is maximal in the G(2)/M phase. Accordingly inhibitors of cell growth, such as p16 and serum starvation, reduce Thr(86) phosphorylation. Finally, we found that cyclin-dependent kinase (CDK)-dependent Thr(86) phosphorylation represses the ability of p73 to induce endogenous p21 expression. Our results demonstrate that p73 proteins are targets of CDK complexes and that phosphorylation on Thr(86) by CDKs regulates p73 functions.
引用
收藏
页码:27421 / 27431
页数:11
相关论文
共 43 条
[1]  
Agami R, 1999, NATURE, V399, P809
[2]   Mdm2 binds p73α without targeting degradation [J].
Bálint, E ;
Bates, S ;
Vousden, KH .
ONCOGENE, 1999, 18 (27) :3923-3929
[3]   Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma [J].
Casciano, I ;
Ponzoni, M ;
Lo Cunsolo, C ;
Tonini, GP ;
Romani, M .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (05) :391-393
[4]   Induction of neuronal differentiation by p73 in a neuroblastoma cell line [J].
De Laurenzi, V ;
Raschellá, G ;
Barcaroli, D ;
Annicchiarico-Petruzzelli, M ;
Ranalli, M ;
Catani, MV ;
Tanno, B ;
Costanzo, A ;
Levrero, M ;
Melino, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) :15226-15231
[5]   Two new p73 splice variants, γ and δ, with different transcriptional activity [J].
De Laurenzi, V ;
Costanzo, A ;
Barcaroli, D ;
Terrinoni, A ;
Falco, M ;
Annicchiarico-Petruzzeli, M ;
Levrero, M ;
Melino, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1763-1768
[6]  
Di Como CJ, 1999, MOL CELL BIOL, V19, P1438
[7]   Inactivation of the p53-homologue p73 by the mdm2-oncoprotein [J].
Dobbelstein, M ;
Wienzek, S ;
König, C ;
Roth, J .
ONCOGENE, 1999, 18 (12) :2101-2106
[8]   Structural principles in cell-cycle control: beyond the CDKs [J].
Endicott, JA ;
Noble, MEM .
STRUCTURE WITH FOLDING & DESIGN, 1998, 6 (05) :535-541
[9]   p63 and p73 are required for p53-dependent apoptosis in response to DNA damage [J].
Flores, ER ;
Tsai, KY ;
Crowley, D ;
Sengupta, S ;
Yang, A ;
McKeon, F ;
Jacks, T .
NATURE, 2002, 416 (6880) :560-564
[10]  
GAIDDON C, 1994, J BIOL CHEM, V269, P22663